Skip to content

Study on the clinical effect evaluation of Chinese patent medicine combined regimen for adenomyosis

Study on the distribution of TCM syndromes of adenomyosis and the evaluation of the clinical advantage of TCM combination therapy: Study on the clinical effect evaluation of Chinese patent medicine combined regimen for adenomyosis (prospective cohort study)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2000002910
Enrollment
Unknown
Registered
2020-01-11
Start date
2020-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Interventions

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) meet the clinical diagnostic criteria of adenomyosis; (2) meet the diagnosis criteria of TCM syndromes; (3) aged >= 25 and <= 50; (4) patients who have not used any drugs with serious effects on liver and kidney function within 3 months; (5) those who voluntarily participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) primary dysmenorrhea, genital cancer or other local or systemic malignant tumors; (2) patients with serious diseases of cardiovascular, cerebrovascular, liver, kidney or hematopoietic system; (3) the introduction period of the case was not suitable for the author, or the case was combined with mental or neurological diseases and could not be cooperated; (4) women who are pregnant or planning to be pregnant recently.

Design outcomes

Primary

MeasureTime frame
Menstrual volume rating table;visual analogue scale (VAS);

Secondary

MeasureTime frame
Transvaginal gynecological ultrasound;TCM syndrome score table;Serum CA125;

Countries

China

Contacts

Public ContactShi Wei

Shandong University of Traditional Chinese Medicine

sw19781214@163.com+86 15153165961

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026